生命科学资讯

Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant

CHMP recommends Moderna's flu-Covid shot and Novartis pill for hives

Moderna’s combination flu, COVID shot wins over European drug regulators

Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more

White House frustration may have fueled FDA’s Moderna walkback: Politico

FDA accepts filing for Moderna flu vaccine after swift rethink

Reversal on Moderna's flu application follows atypical path through FDA

FDA reverses course on Moderna’s flu vaccine

FDA reverses course, will review Moderna’s flu vaccine

Moderna faces setback in Arbutus' mRNA patent fight

Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more

With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment

Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg

Moderna's flu shot dilemma muddies 2028 break-even guidance

Moderna shares jump as company affirms growth outlook

UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing

FDA may consider Moderna's flu vaccine in a narrower group

Prasad overruled vaccine review team, office director on Moderna flu shot

Moderna dips on flu vaccine RTF letter